Injective Labs unveils real-time position monitoring feature
Injective (INJ)
Editor:
Eugene Serbin
tradersunion.com reports that Eric Chen, co-founder and CEO of Injective Labs, highlighted a new feature on the Injective Protocol. This tool allows users to receive real-time updates and alerts regarding their open positions. It enables traders to monitor which positions are profitable and which are close to being liquidated. Chen previously discussed onchain IPOs and expressed optimism about new uses for blockchain infrastructure.
How the market reacted
Whalio's own Binance spot order flow for INJ, measured when this story was written up on 30 September 2026. Not the outlet's figures.
INJ trades at $7.62 with a 1-hour buy ratio of 53.9%, indicating short-term buying dominance. This contrasts with the 4-hour buy ratio of 46.7%, suggesting that buying pressure is fading over a slightly longer timeframe. The 24-hour buy ratio sits at 51.9%, showing a balanced but slightly bullish sentiment over the day. Volume Delta is positive at +$34,690 for the hour and +$565,481 for the day, meaning buyers are actively absorbing sell orders. Cumulative Volume Delta closes at +$425,726, confirming net inflow into spot markets.
The latest daily buy ratio of 53.4% sits at the 91st percentile of the last 322 days, against a median of 49.8% - among the strongest buying days it has had.
Was that an ordinary day?
The same Binance spot measurements for INJ, averaged over the days leading up to the story.
Over the preceding week, the buy ratio averaged 49.3%, making today's 24-hour ratio of 51.9% slightly above normal. Volume relative to average is 0.83x, indicating lighter trading activity than usual. The price dropped 3.6% over eight days, with a total Volume Delta of -$1,698,942. This daily positive flow is an unusual deviation from the week's net selling trend.